Poland has emerged as the 6th largest cosmetics market in Europe. With a growing middle class in cities like Kraków, Wrocław, and Gdańsk, the demand for high-end aesthetic treatments has surged by 18% annually. Stretch mark care is no longer a niche; it is a core revenue driver for Polish dermatological clinics.
Entering the Polish market requires strict adherence to European Medical Device Regulations (MDR). As a leading manufacturer, Menuka Medical ensures all laser systems and topical treatments meet ISO 13485 standards and CE certification, providing Polish distributors with a "frictionless" import experience.
There is a notable trend in Poland toward "Lunch-break Procedures." Patients prefer Fractional CO2 lasers and RF Microneedling because of the reduced downtime compared to traditional surgical scar revision. Our tech roadmap focuses on high-peak power with minimal thermal damage to surrounding tissue.
Founded in 2009, Jiangsu Menuka Medical Co., Ltd. is a global powerhouse in the field of medical skincare and dermatological innovation. We bridge the gap between clinical research and commercial application, providing the Polish market with tools that deliver measurable results.
With a 15,000 sqm intelligent manufacturing facility, we specialize in high-energy laser devices and functional "cosmeceuticals" that address deep-tissue repair.
We are integrating Exosome technology (as seen in our Exoxe line) with laser treatments. In the Polish market, clinics are seeing 40% faster healing times when using exosomes post-CO2 laser.
Our 2026 models feature AI sensors that analyze skin density and moisture levels to automatically calibrate laser intensity, reducing the risk of hyperpigmentation in sensitive Polish skin types (Fitzpatrick I-III).
The combination of mechanical needling and radiofrequency energy (Morpheus 8 technology) is the current "Gold Standard" in Warsaw for abdominal stretch mark tightening.
Water Treatment
Emulsifying
Filling
Labeling
QC Control
Packing
Thermal Film
Emulsification
Mask Filling